Selective Inhibitors of Fibroblast Activation Protein (FAP) with a (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine Scaffold
- 30 April 2013
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Medicinal Chemistry Letters
- Vol. 4 (5), 491-496
- https://doi.org/10.1021/ml300410d
Abstract
Fibroblast activation protein (FAP) is a serine protease that is generally accepted to play an important role in tumor growth and other diseases involving tissue remodeling. Currently there are no FAP inhibitors with reported selectivity toward both the closely related dipeptidyl peptidases (DPPs) and prolyl oligopeptidase (PREP). We present the discovery of a new class of FAP inhibitors with a N-(4-quinolinoyl)-Gly-(2-cyanopyrrolidine) scaffold. We have explored the effects of substituting the quinoline ring and varying the position of its sp(2) hybridized nitrogen atom. The most promising inhibitors combined low nanomolar FAP inhibition and high selectivity indices (>10(3)) with respect to both the DPPs and PREP. Preliminary experiments on a representative inhibitor demonstrate that plasma stability, kinetic solubility, and log D of this class of compounds can be expected to be satisfactory.Keywords
This publication has 28 references indexed in Scilit:
- Acylated Gly-(2-cyano)pyrrolidines as inhibitors of fibroblast activation protein (FAP) and the issue of FAP/prolyl oligopeptidase (PREP)-selectivityBioorganic & Medicinal Chemistry Letters, 2012
- Fibroblast activation protein is induced by inflammation and degrades type I collagen in thin-cap fibroatheromataEuropean Heart Journal, 2011
- Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in miceJCI Insight, 2009
- Phase II assessment of talabostat and cisplatin in second-line stage IV melanomaBMC Cancer, 2009
- Enzyme Activity and Immunohistochemical Localization of Dipeptidyl Peptidase 8 and 9 in Male Reproductive TissuesJournal of Histochemistry & Cytochemistry, 2009
- Emerging roles of serine proteinases in tissue turnover in arthritisArthritis & Rheumatism, 2008
- Fibroblast activation protein and chronic liver diseaseFrontiers in Bioscience-Landmark, 2008
- Synthesis and structure–activity relationship of N-acyl-Gly-, N-acyl-Sar- and N-blocked-boroPro inhibitors of FAP, DPP4, and POPBioorganic & Medicinal Chemistry Letters, 2007
- Synthesis and structure–activity relationship of N-alkyl Gly-boro-Pro inhibitors of DPP4, FAP, and DPP7Bioorganic & Medicinal Chemistry Letters, 2005
- Structural and Kinetic Analysis of the Substrate Specificity of Human Fibroblast Activation Protein αPublished by Elsevier BV ,2005